Heart stent showdown: dissolving scaffold vs. standard stents – trial pulled before start
Disease control
Terminated
This study aimed to see if a new type of heart stent that slowly dissolves (MeRes100) works as well as standard permanent stents in people with blocked heart arteries. The trial was planned for about 60 hospitals worldwide but was withdrawn before any patients joined. No results …
Phase: NA • Sponsor: Meril Life Sciences Pvt. Ltd. • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC